Procter & Gamble price target raised to $171 from $162 at JPMorgan

JPMorgan raised the firm’s price target on Procter & Gamble to $171 from $162 and keeps an Overweight rating on the shares post the fiscal Q2 report. The company not only positively surprised investors due to better than anticipated 4% and 3% volume growth in the U.S. and European Focus markets, it accelerated unit growth on a sequential basis, as pricing was lapped, the analyst tells investors in a research note.